LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,233 | -14.8% | 20,635 | +2.8% | 0.00% | 0.0% |
Q2 2023 | $1,448 | +8.1% | 20,082 | +10.2% | 0.00% | 0.0% |
Q1 2023 | $1,339 | +2.2% | 18,231 | -7.1% | 0.00% | 0.0% |
Q4 2022 | $1,310 | -99.9% | 19,624 | -4.6% | 0.00% | -40.0% |
Q3 2022 | $1,771,000 | +19.6% | 20,570 | +23.6% | 0.01% | +25.0% |
Q2 2022 | $1,481,000 | -10.6% | 16,644 | +15.7% | 0.00% | +33.3% |
Q1 2022 | $1,657,000 | -25.7% | 14,386 | -0.7% | 0.00% | -40.0% |
Q4 2021 | $2,231,000 | +9.1% | 14,484 | -0.6% | 0.01% | 0.0% |
Q3 2021 | $2,044,000 | +144.5% | 14,574 | +128.5% | 0.01% | +150.0% |
Q2 2021 | $836,000 | -13.9% | 6,379 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $971,000 | +40.5% | 6,379 | -8.2% | 0.00% | +100.0% |
Q4 2020 | $691,000 | -5.2% | 6,949 | -9.4% | 0.00% | -50.0% |
Q3 2020 | $729,000 | -19.8% | 7,667 | -5.7% | 0.00% | 0.0% |
Q2 2020 | $909,000 | +47.8% | 8,130 | -4.2% | 0.00% | 0.0% |
Q1 2020 | $615,000 | -31.4% | 8,489 | -2.0% | 0.00% | 0.0% |
Q4 2019 | $896,000 | -34.4% | 8,663 | -27.6% | 0.00% | -33.3% |
Q2 2019 | $1,365,000 | -13.7% | 11,965 | -4.9% | 0.00% | -25.0% |
Q1 2019 | $1,581,000 | -2.0% | 12,582 | -1.8% | 0.00% | -20.0% |
Q4 2018 | $1,613,000 | -77.8% | 12,813 | -51.5% | 0.01% | -70.6% |
Q3 2018 | $7,250,000 | +28.6% | 26,425 | -2.9% | 0.02% | +30.8% |
Q2 2018 | $5,639,000 | +21.7% | 27,222 | -3.0% | 0.01% | +18.2% |
Q1 2018 | $4,635,000 | +21.7% | 28,062 | +0.9% | 0.01% | +22.2% |
Q4 2017 | $3,808,000 | +0.1% | 27,817 | -1.6% | 0.01% | 0.0% |
Q3 2017 | $3,805,000 | +13.3% | 28,265 | +2.2% | 0.01% | 0.0% |
Q2 2017 | $3,359,000 | +18.8% | 27,666 | +3.6% | 0.01% | +12.5% |
Q1 2017 | $2,827,000 | +10.5% | 26,716 | +6.1% | 0.01% | +14.3% |
Q4 2016 | $2,558,000 | -51.0% | 25,169 | -50.8% | 0.01% | -12.5% |
Q3 2016 | $5,218,000 | +77.1% | 51,132 | +106.8% | 0.01% | -11.1% |
Q2 2016 | $2,947,000 | +1215.6% | 24,724 | +1078.5% | 0.01% | +800.0% |
Q1 2016 | $224,000 | +52.4% | 2,098 | +55.3% | 0.00% | 0.0% |
Q4 2015 | $147,000 | +26.7% | 1,351 | 0.0% | 0.00% | – |
Q3 2015 | $116,000 | -14.7% | 1,351 | 0.0% | 0.00% | – |
Q2 2015 | $136,000 | +30.8% | 1,351 | 0.0% | 0.00% | – |
Q1 2015 | $104,000 | +44.4% | 1,351 | 0.0% | 0.00% | – |
Q4 2014 | $72,000 | +12.5% | 1,351 | 0.0% | 0.00% | – |
Q3 2014 | $64,000 | -23.8% | 1,351 | 0.0% | 0.00% | – |
Q2 2014 | $84,000 | -6.7% | 1,351 | 0.0% | 0.00% | – |
Q1 2014 | $90,000 | +25.0% | 1,351 | 0.0% | 0.00% | – |
Q4 2013 | $72,000 | – | 1,351 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |